Evidence map›Paper›PMID 23452077›Full record

ArticleJournal of the American Geriatrics Society2013

Refining physician quality indicators for screening mammography in older women: distinguishing appropriate use from overuse.

Alai Tan, Yong-Fang Kuo, Linda S Elting, James S Goodwin

Abstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Receipt of Cancer Screening Is a Predictor of Life Expectancy.Journal of general internal medicine · 2016
    Article
  5. Article
  6. Limited life expectancy among a subgroup of medicare beneficiaries receiving screening colonoscopies.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2014
    Article
  7. Article
  8. Delivering high-quality and affordable care throughout the cancer care continuum.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2013
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alai TanSealy Center on Aging, University of Texas Medical Branch, Galveston, TX 77555, USA. altan@utmb.edu
Yong-Fang Kuo
Linda S Elting
James S Goodwin

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Established Investigator Award in Cancer Prevention & ControlK05CA134923 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI GOODWIN, MD, JAMES S. · 2008 to 2019
$1.0M
NCATS NIH HHS 8UL1TR000071NCATS NIH HHS UL1 TR000071NCI NIH HHS K05 CA134923NCI NIH HHS K05CA134923NIA NIH HHS 5P30AG024832-08NIA NIH HHS P30 AG024832
6 · The paper itself

Abstract

objectivesTo assess the feasibility of refining physician quality indicators of screening mammography use based on patient life expectancy.

designRetrospective population-based cohort study.

settingTexas.

participantsThree thousand five hundred ninety-five usual care providers (UCPs) with at least 10 female patients aged 67 and older on January 1, 2008, with an estimated life expectancy of 7 years or more (222,584 women) and at least 10 women with an estimated life expectancy of less than 7 years (90,903 women), based on age and comorbidity. MEASUREMENTS: Screening mammography use in 2008-09 by each provider in each population.

resultsThe average adjusted mammography screening rates for UCPs were 31.1% for women with a life expectancy of less than 7 years and 55.2% for women with a life expectancy of 7 years or longer. For women with limited life expectancy, 3.7% of UCPs had significantly lower and 9.2% had significantly higher than average adjusted mammography screening rates. For women with longer life expectancy, 16.7% of UCPs had significantly lower and 19.7% had significantly higher than average rates. UCP adjusted screening rates were stable over time (2006-07 vs 2008-09, correlation coefficient (r) = 0.65, P < .001). There was a strong correlation between UCP screening rates for their female patients with a life expectancy of less than 7 years and 7 years or longer (r = 0.67, P < .001). Most physician characteristics associated with higher screening rates (e.g., being female and foreign trained) in women with longer life expectancy were also associated with higher screening rates in women with limited life expectancy.

conclusionProviders with high mammography screening rates for women with longer life expectancy also tend to screen women with limited life expectancy. Quality indicators for screening practice can be improved by distinguishing appropriate use from overuse based on patient life expectancy.

Indexed as

Practice Patterns, Physicians'Quality Indicators, Health CareAgedAged, 80 and overFemaleGeriatric AssessmentHumansLife ExpectancyMammographyMass ScreeningMedicarePatient SelectionTexasUnited StatesUnnecessary Procedures

Identifiers

PMID23452077
PMCPMC3602404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.